The 2017 Conference on Tuberculosis Drug Discovery and Development will explore the entire process of drug discovery from clinical development of new drugs for tuberculosis (TB) to the underlying biology of Mycobacterium tuberculosis that impacts drug discovery efforts. The conference will address the unique challenges in TB drug discovery through discussion of clinical trial design, complimentary approaches to identification of lead compounds, vulnerable targets and pathways, host-directed therapies, and non-traditional approaches to TB prevention and treatment. We invite researchers interested in all aspects of drug discovery and development and welcome participants from academia, industry, government and non-governmental organizations. In particular, we invite trainees and scientists from TB-endemic countries to apply, as their contribution to the struggle against TB is especially important. All participants are asked to submit abstracts of their work for presentation as posters, and some abstracts will be chosen for oral presentations. The conference provides the opportunity to interact with colleagues in an informal and intimate atmosphere and is designed to promote extensive discussion. In the past, the meeting has been oversubscribed – please apply early!